Strair, Roger External Entity

Publications

Sort by

Selected publications

  • A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies.  Clinical cancer research : an official journal of the American Association for Cancer Research2008 Academic Article GET IT